Filing Flows › Arcus Biosciences (RCUS) › Recalls, complaints & regulation
Arcus Biosciences (RCUS): clinical trials
Arcus Biosciences (RCUS) beyond its filings: 6 active clinical trials.
Arcus Biosciences' latest quarter
Arcus Biosciences, Q3 2026: revenue $9.0M (-65% year over year), net loss $128M, operating cash flow −$88.0M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does Arcus Biosciences have?
6 active studies on ClinicalTrials.gov, 2 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.